Author

C. R. Jimenez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

S. R. Piersma· 2 shared A. Duarte· 1 shared A. Erozenci· 1 shared A. Valles Marti· 1 shared B. Morris· 1 shared B. van den Broek· 1 shared C. Lieftink· 1 shared D. Dekker· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. R. Piersma

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Large pan-cancer cell screen coupled to (phospho-) proteomics underscores high-dose vitamin C as a potent anti-cancer agent

A. Valles Marti, F. Böttger, E. Yau, K. Tejjani, L. Meijs, S. Sharma, M. Mumtaz, T. Le Large, A. Erozenci, D. Dekker, T. Schelfhorst, J. P. Medema, I. V. Bijnsdorp, J. C. Knol, S. R. Piersma, , C. R. Jimenez

This study evaluates high-dose vitamin C's anti-cancer effects across 51 cancer cell lines, finding high sensitivity and proteomic changes linked to cell cycle and immune pathways.

bioRxiv · Dec 19, 2023 · PreprintCancer Biology

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors

J. Bhin, M. Paes Dias, E. Gogola, F. Rolfs, S. R. Piersma, R. de Bruijn, J. de Ruiter, B. van den Broek, A. Duarte, W. Sol, I. van der Heijden, L. Bakker, T. S. Kaiponen, C. Lieftink, B. Morris, , J. Jonkers

bioRxiv · Sep 7, 2022Cancer Biology